By Denny Jacob
GE HealthCare trimmed its estimates for the year after assuming the impact of tariffs on its outlook.
The maker of magnetic-resonance imaging scanners and other health-care machines now expects adjusted earnings per-share to be in the range of $3.90 to $4.10. It previously guided for adjusted earnings between $4.61 a share and $4.75 a share.
Free cash flow is now expected to be at least $1.2 billion, down from prior guidance calling for at least $1.75 billion.
Chief Executive Peter Arduini said the company is actively driving mitigation actions in regards to the current global trade environment.
The Chicago company logged net income of $564 million, or $1.23 a share, up from $374 million, or 81 cents a share, in the prior-year period.
Stripping out certain one-time items, earnings came in at $1.01 a share. Analysts polled by FactSet expected 91 cents a share.
Revenue rose to $4.78 billion from $4.65 billion. Analysts polled by FactSet expected $4.66 billion.
GE HealthCare said revenue growth was broad-based with growth in each segment, with overall strength in the U.S.
GE HealthCare also announced its board authorized the repurchase of up to $1 billion of the company's common stock.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
April 30, 2025 07:12 ET (11:12 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。